Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs.

× No keyword cloud information.

7 in total

1. Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting.

Authors: J W Dundee; R G Ghaly; K M Bill; W N Chestnutt; K T Fitzpatrick; A G Lynas
Journal: Br J Anaesth Date: 1989-11 Impact factor: 9.166

Review 2. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes.

Authors: H J Schmoll
Journal: Eur J Cancer Clin Oncol Date: 1989

3. Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

Authors: M G Kris; R J Gralla; L B Tyson; R A Clark; D P Kelsen; L K Reilly; S Groshen; G J Bosl; L A Kalman
Journal: Cancer Date: 1985-02-01 Impact factor: 6.860

4. Acupuncture prophylaxis of cancer chemotherapy-induced sickness.

Authors: J W Dundee; R G Ghaly; K T Fitzpatrick; W P Abram; G A Lynch
Journal: J R Soc Med Date: 1989-05 Impact factor: 18.000

5. Prolongation of the antiemetic action of P6 acupuncture by acupressure in patients having cancer chemotherapy.

Authors: J W Dundee; J Yang
Journal: J R Soc Med Date: 1990-06 Impact factor: 18.000

6. Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy.

Authors: J W Dundee; J Yang; C McMillan
Journal: J R Soc Med Date: 1991-04 Impact factor: 18.000

7. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.

Authors: D B Smith; E S Newlands; O W Spruyt; R H Begent; G J Rustin; B Mellor; K D Bagshawe
Journal: Br J Cancer Date: 1990-02 Impact factor: 7.640

7 in total

3 in total

Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs.